title: Will statins be an effective anti-inflammatory intervention for prevention of cardiovascular disease in patients with HIV?
authors.affiliation: Department of Medicine and Division of Infectious Diseases, University of Southern California Keck School of Medicine, Los Angeles, California.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Dubé
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D005260:Female; D005464:Fluorobenzenes / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*; D014657:Vasculitis / Q000188:drug therapy*
chemical_list: D044966:Anti-Retroviral Agents; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium
keywords: HIV; HMG-CoA reductase inhibitors; immune activation; inflammation; lipids; rosuvastatin